Hycodan

Acute Bronchitis, Pain, Chronic Pain + 10 more

Treatment

2 FDA approvals

10 Active Studies for Hycodan

What is Hycodan

Hydrocodone

The Generic name of this drug

Treatment Summary

Hydrocodone is an opioid medication used to relieve moderate to severe pain. It is often combined with acetaminophen for better pain relief. In the past, hydrocodone was used as a cough suppressant, but it has been replaced by dextromethorphan in cough and cold medicines. Its metabolite, hydromorphone, is sometimes given to treat severe pain. Hydrocodone was first approved by the FDA in 1943 as part of the cough suppressant syrup Hycodan.

Hycodan

is the brand name

image of different drug pills on a surface

Hycodan Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Hycodan

Hydrocodone

1943

1122

Approved as Treatment by the FDA

Hydrocodone, otherwise called Hycodan, is approved by the FDA for 2 uses including Pain and Pain .

Pain

Used to treat Severe Pain in combination with Acetaminophen

Pain

Helps manage moderate Pain

Effectiveness

How Hycodan Affects Patients

Hydrocodone reduces pain signals sent to both the brain and spinal cord. It can also cause feelings of happiness, slower breathing, and sleepiness.

How Hycodan works in the body

Hydrocodone works by binding to two types of opioid receptors, mu and delta. The mu receptor produces most of the drug's pain relieving effects. When hydrocodone binds to these receptors, it causes nerve cells in the spinal cord to become more relaxed. This dampens pain signals from reaching the brain. Hydrocodone also binds to opioid receptors in the brain and can reduce pain signals from reaching the brain. This drug also blocks inhibitory signals from an area in the brain called the periaquaductal gray, which reduces pain signals from reaching the brain. Hydrocodone also can increase dopamine levels in

When to interrupt dosage

The recommended measure of Hycodan is contingent upon the recognized ailment, including Coughing, Coughing and Chronic Pain. The amount likewise fluctuates as per the technique of delivery (e.g. Tablet, extended release - Oral or Tablet - Oral) featured in the table beneath.

Condition

Dosage

Administration

Acute Bronchitis

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Pain

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Chronic Pain

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Inflammation

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Pain

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Acute Pain

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Rhinitis, Allergic

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Rhinitis

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Common Cold

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Allergic rhinitis (disorder)

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Coughing

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Common Cold

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Coughing

7.5 mg, , 5.0 mg, 10.0 mg, 1.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.75 mg/mL, 0.075 mg/mL, 2.5 mg, 10.0 mg/mL, 15.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 50.0 mg, 60.0 mg, 80.0 mg, 100.0 mg, 120.0 mg, 0.5 mg/mL, 90.0 mg, 750.0 mg, 45.0 mg, 3.0 mg/mL, 0.33 mg/mL, 1.65 mg/mL, 1.7 mg/mL, 1.667 mg/mL, 1.8 mg/mL, 1.67 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Syrup - Oral, Syrup, Capsule, extended release, Capsule, extended release - Oral, Solution - Oral, Solution, Tablet, Tablet - Oral, Suspension, extended release, Suspension, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Kit, Tablet, extended release, Suspension, Suspension - Oral, Tablet, extended release - Oral, Liquid - Oral, Liquid, Topical, Cream - Topical, Cream, Elixir, Elixir - Oral, Capsule, Capsule - Oral

Warnings

Hycodan Contraindications

Condition

Risk Level

Notes

Intestinal Pseudo-Obstruction

Do Not Combine

Asthma

Do Not Combine

Intracranial Hypertension

Do Not Combine

Status Asthmaticus

Do Not Combine

Asthma

Do Not Combine

increased cerebrospinal pressure

Do Not Combine

Mental Depression

Do Not Combine

Pulmonary Heart Disease

Do Not Combine

Abdomen

Do Not Combine

Epilepsy

Do Not Combine

Pulmonary Disease, Chronic Obstructive

Do Not Combine

ethanol

Do Not Combine

Gastrointestinal obstruction

Do Not Combine

Alcohol Withdrawal Delirium

Do Not Combine

Asthma

Do Not Combine

Hypercarbia

Do Not Combine

Asthma

Do Not Combine

severe CNS depression

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Hydrocodone may interact with Pulse Frequency

There are 20 known major drug interactions with Hycodan.

Common Hycodan Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Hydrocodone.

Azelastine

Major

Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Cyclophosphamide

Major

The metabolism of Cyclophosphamide can be decreased when combined with Hydrocodone.

Eluxadoline

Major

The risk or severity of constipation can be increased when Hydrocodone is combined with Eluxadoline.

Enasidenib

Major

The metabolism of Enasidenib can be decreased when combined with Hydrocodone.

Hycodan Toxicity & Overdose Risk

Taking too much hydrocodone can lead to an opioid overdose, which can cause breathing difficulty, drowsiness, unconsciousness, weak muscles, cold and clammy skin, small pupils, fluid in the lungs, slow heart rate, low blood pressure, blocked airways, and death. In case of an overdose, the main priority is to keep the airway open and provide assisted breathing if necessary. Other treatments may include fluids, oxygen, and drugs to increase blood pressure. Cardiac arrest or arrhythmias may require advanced life support. Naloxone can be used to reverse the effects of hydrocodone,

Hycodan Novel Uses: Which Conditions Have a Clinical Trial Featuring Hycodan?

50 active clinical trials are currently evaluating the potential of Hycodan to alleviate Chronic Pain, Nasal Congestion due to Common Cold and Acute Bronchitis.

Condition

Clinical Trials

Trial Phases

Acute Pain

1 Actively Recruiting

Not Applicable

Chronic Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Acute Bronchitis

7 Actively Recruiting

Phase 4, Not Applicable, Phase 3, Early Phase 1

Common Cold

0 Actively Recruiting

Allergic rhinitis (disorder)

0 Actively Recruiting

Rhinitis

0 Actively Recruiting

Inflammation

0 Actively Recruiting

Coughing

0 Actively Recruiting

Coughing

0 Actively Recruiting

Common Cold

0 Actively Recruiting

Hycodan Reviews: What are patients saying about Hycodan?

5

Patient Review

1/9/2013

Hycodan for Cough

This medication was a successful relief from my night time continuous coughing.

5

Patient Review

4/14/2011

Hycodan for Cough

This cough medicine was incredibly effective, to the point where my cough was completely gone. However, I started experiencing itchiness all over my body, and while it made me feel sleepy, I kept waking up every 15-20 minutes. It's a shame that I won't be able to use this medication anymore.

5

Patient Review

11/21/2011

Hycodan for Cough

This bronchitis medicine was a godsend. I couldn't sleep at all the night before I started taking it, but within 20 minutes of my first dose I found myself feeling so much better. It's also affordable, which is great because my insurance won't cover any cough medicines. Overall, would highly recommend this medication to anyone else suffering from bronchitis!

5

Patient Review

4/18/2012

Hycodan for Cough

Super easy to use and provides very quick relief from coughing.

5

Patient Review

10/17/2014

Hycodan for Cough

This medication is a great way to address coughing, insomnia and headaches all at once.

5

Patient Review

11/13/2010

Hycodan for Cough

5

Patient Review

10/15/2011

Hycodan for Cough

Though it makes me drowsy, I appreciate the relief from pain that this medication offers.

5

Patient Review

12/1/2015

Hycodan for Cough

This treatment is effective.

4.7

Patient Review

4/20/2012

Hycodan for Cough

I started taking the liquid form yesterday and saw quick results. My cough was gone almost immediately, and the pain I was feeling in my chest and back has greatly decreased. This medication has been a lifesaver!

4.7

Patient Review

5/23/2011

Hycodan for Cough

I've been taking this medication for three days now, and I haven't seen any improvement in my cough. Maybe I'm just the odd one out.

4.7

Patient Review

9/30/2011

Hycodan for Cough

This drug quickly stopped my nighttime cough, but it is very addictive.

4

Patient Review

1/21/2011

Hycodan for Cough

I'm grateful for this cough medicine. It worked better than codeine syrup for me, and it helped control my cough so that the antibiotics could work.

4

Patient Review

8/12/2014

Hycodan for Cough

I was hesitant to go to the doctor when I started feeling ill, but I'm so glad that I did. This medication has helped me immensely and gotten me on the road to recovery.

3.7

Patient Review

1/10/2014

Hycodan for Cough

This medication is great for an extreme cough that resulted from my bronchitis. I found it worked best when taken a few hours before bedtime. It can make me feel a bit jittery at first, but then I start to feel relaxed and sleepy. This suppresses my cough much better than Robitussin with codeine.

3

Patient Review

10/19/2012

Hycodan for Cough

I had a cough that gradually got worse and worse, to the point where I couldn't sleep. Eventually, I saw a doctor and found out I had bronchitis. This syrup was recommended to me, and it worked within 15-20 minutes to ease the coughing and muscle pain. It's been very effective in helping me get over bronchitis.

3

Patient Review

12/12/2010

Hycodan for Cough

2

Patient Review

3/9/2011

Hycodan for Cough

This medication does a great job at suppressing coughing. However, it can make it tough to sleep if you take it too close to bedtime.

Patient Q&A Section about hycodan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Hycodan have hydrocodone in it?

"…a semisynthetic opioid antitussive that acts on the central nervous system."

Answered by AI

What class of drug is Hycodan?

"Opioids are drugs that have a high potential for abuse and dependence. Hydrocodone bitartrate and homatropine methylbromide (Hycodan) is a Schedule III opioid, meaning it has a high potential for abuse but also has legitimate medical uses."

Answered by AI

Is Hycodan and hydrocodone the same?

"Many drugs are commonly prescribed for off label indications in veterinary medicine.

Hydrocodone bitartrate, marketed under the brand names Tussigon®, Hycodan®, Vicodin®, Norco®, and Lortabs®, is an opiate agonist used to treat pain and cough in dogs. Its use in dogs to treat pain and cough is 'off label' or 'extra-label'. Many drugs are commonly prescribed for off label indications in veterinary medicine."

Answered by AI

Clinical Trials for Hycodan

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Image of University of California San Diego in San Deigo, United States.

Omeprazole + Lifestyle Therapy for Laryngopharyngeal Reflux

18 - 89
All Sexes
San Deigo, CA

The goal of this clinical trial is to learn if a mechanism guided strategy that utilizes a multidisciplinary approach to treat adults patients (age 18-89) with chronic throat symptoms who are undergoing clinical evaluation for laryngopharyngeal reflux (LPR) is more effective than the usual care strategy with proton pump inhibitor (PPI) therapy used in gastroenterology for these patients. The main question it aims to answer is: Will a greater proportion of the mechanism guided strategy participants achieve symptom response in comparison to the usual care strategy participants? If there is a comparison group: Researchers will compare the mechanism guided strategy to usual care strategy to see if treatment response differs between the groups. Participants will be be asked to do the following: * participate in an 8-week blinded study phase where they will be randomized to either 1) Mechanism Guided Strategy or 2) Usual Care Strategy * take an oral capsule daily (omeprazole 40mg or placebo) * come to 3 in-person visits at UC San Diego Health for an intervention visit with a study provider * consider incorporating recommended lifestyle modifications * complete weekly surveys

Phase 4
Recruiting

University of California San Diego

Rena Yadlapati, MD

Image of Medical University of South Carolina in Charleston, United States.

Steroid Injection for Chronic Cough

18+
All Sexes
Charleston, SC

The primary goal of this study is to test the hypothesis that injecting steroid intramuscularly is an effective treatment for unexplained chronic cough. This will be achieved through the design of a prospective, placebo-controlled, single-blind, randomized clinical trial in which one group of patients will undergo a steroid injection into the deltoid muscle and the second group will undergo a placebo injection into the deltoid muscle. Data to determine if a clinically significant difference exists between the outcomes of the two groups will be measured by a dichotomous yes/no response to improvement, the Leicester Cough Questionnaire, and a visual analogue scale for symptom severity. This will provide the answer to the general question of whether or not the intramuscular injections are clinically effective for patients with unexplained chronic cough. Furthermore, any adverse reactions will be thoroughly documented. If this hypothesized treatment is proven effective, this can greatly improve the care of chronic cough patients by allowing for an evidence-based treatment option and a treatment option that may improve access to care. While the superior laryngeal nerve (SLN) injection is typically performed by fellowship trained laryngologists, intramuscular injections could be more widely utilized by general otolaryngologists or providers in other fields of medicine.

Phase < 1
Recruiting

Medical University of South Carolina

Lauren Howser

Have you considered Hycodan clinical trials?

We made a collection of clinical trials featuring Hycodan, we think they might fit your search criteria.
Go to Trials

Have you considered Hycodan clinical trials?

We made a collection of clinical trials featuring Hycodan, we think they might fit your search criteria.
Go to Trials